SCHEMBL802622

SCHEMBL802622

COc1ccc2c(c1)COc1cc(O)ccc1-2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.57
MAPT P10636 4/20 0.49
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
GAA P10253 2/20 0.49
NPC1 O15118 1/20 0.49
ALOX12 P18054 1/20 0.49
RAB9A P51151 1/20 0.49
ESRRB O95718 2/20 0.48
ESRRA P11474 2/20 0.48
CYP3A4 P08684 3/20 0.46
MAPK14 Q16539 2/20 0.46
KIT P10721 1/20 0.45
ROCK2 O75116 1/20 0.45
MEN1 O00255 2/20 0.44
USP2 O75604 2/20 0.44
ALOX15 P16050 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802750 0.84 MAOA (0.49) MAOBMAPTALDH1A1RAB9AESRRB
SCHEMBL30577530 0.84 MAOA (0.49) MAOBMAPTALDH1A1RAB9AESRRB
SCHEMBL7808175 0.83 MAPT (0.69) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL23409967 0.82 KDM4E (0.58) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL29757624 0.82 KDM4E (0.58) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL805442 0.82 MEN1 (0.56) MAOBMAPTALDH1A1GAANPC1
SCHEMBL26768220 0.80 MAOB (0.42) MAOBMAPTALDH1A1RAB9AESRRB
SCHEMBL3195849 0.79 MAPT (0.49) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL6121014 0.79 MAPT (0.47) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL803144 0.78 MAOB (0.66) MAOBMAPTKDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096795-B2 Liquid crystal display MERCK PATENT GMBH (DE) 2015-08-04 US disclosed
US-9096795-B2 Liquid crystal display MERCK PATENT GMBH (DE) 2015-08-04 US disclosed
EP-2432851-B1 LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2013-10-02 EP disclosed
US-20120069289-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-03-22 US disclosed
US-20120069289-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-03-22 US disclosed
WO-2010133278-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120069289-A1 LIQUID CRYSTAL DISPLAY LPXN, VCL, ACP3 MAOB 2889/4885MAPT 38/4885KDM4E 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.